Predicting pathological complete response in breast cancer early

被引：15

作者：

Groheux, David ^{[1
]}

机构：

[1] Hop St Louis, Dept Nucl Med, F-75475 Paris 10, France

来源：

LANCET ONCOLOGY | 2014年 / 15卷 / 13期

关键词：

NEOADJUVANT CHEMOTHERAPY;

D O I：

10.1016/S1470-2045(14)71020-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1415 / 1416

页数：3

共 10 条

[1] Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].

Cortazar, Patricia ;

Zhang, Lijun ;

Untch, Michael ;

Mehta, Keyur ;

Costantino, Joseph P. ;

Wolmark, Norman ;

Bonnefoi, Herve ;

Cameron, David ;

Gianni, Luca ;

Valagussa, Pinuccia ;

Swain, Sandra M. ;

Prowell, Tatiana ;

Loibl, Sibylle ;

Wickerham, D. Lawrence ;

Bogaerts, Jan ;

Baselga, Jose ;

Perou, Charles ;

Blumenthal, Gideon ;

Blohmer, Jens ;

Mamounas, Eleftherios P. ;

Bergh, Jonas ;

Semiglazov, Vladimir ;

Justice, Robert ;

Eidtmann, Holger ;

Paik, Soonmyung ;

Piccart, Martine ;

Sridhara, Rajeshwari ;

Fasching, Peter A. ;

Slaets, Leen ;

Tang, Shenghui ;

Gerber, Bernd ;

Geyer, Charles E., Jr. ;

Pazdur, Richard ;

Ditsch, Nina ;

Rastogi, Priya ;

Eiermann, Wolfgang ;

von Minckwitz, Gunter .

LANCET, 2014, 384 (9938) :164-172

[2]

Coudert B, 2014, LANCET ONCOL

[3] HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment [J].

Groheux, D. ;

Giacchetti, S. ;

Hatt, M. ;

Marty, M. ;

Vercellino, L. ;

de Roquancourt, A. ;

Cuvier, C. ;

Coussy, F. ;

Espie, M. ;

Hindie, E. .

BRITISH JOURNAL OF CANCER, 2013, 109 (05) :1157-1164

[4] Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer [J].

Groheux, David ;

Hindie, Elif ;

Giacchetti, Sylvie ;

Hamy, Anne-Sophie ;

Berger, Frederique ;

Merlet, Pascal ;

de Roquancourt, Anne ;

de Cremoux, Patricia ;

Marty, Michel ;

Hatt, Mathieu ;

Espie, Marc .

EUROPEAN JOURNAL OF CANCER, 2014, 50 (11) :1864-1871

[5] Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer [J].

Groheux, David ;

Hindie, Elif ;

Delord, Marc ;

Giacchetti, Sylvie ;

Hamy, Anne-sophie ;

de Bazelaire, Cedric ;

de Roquancourt, Anne ;

Vercellino, Laetitia ;

Toubert, Marie-Elisabeth ;

Merlet, Pascal ;

Espie, Marc .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (24) :1879-1887

[6] Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim [J].

Groheux, David ;

Giacchetti, Sylvie ;

Espie, Marc ;

Rubello, Domenico ;

Moretti, Jean-luc ;

Hindie, Elif .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (03) :419-425

[7] Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes [J].

Humbert, O. ;

Berriolo-Riedinger, A. ;

Riedinger, J. M. ;

Coudert, B. ;

Arnould, L. ;

Cochet, A. ;

Loustalot, C. ;

Fumoleau, P. ;

Brunotte, F. .

ANNALS OF ONCOLOGY, 2012, 23 (10) :2572-2577

[8] Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study [J].

Pierga, Jean-Yves ;

Petit, Thierry ;

Delozier, Thierry ;

Ferrero, Jean-Marc ;

Campone, Mario ;

Gligorov, Joseph ;

Lerebours, Florence ;

Roche, Henri ;

Bachelot, Thomas ;

Charafe-Jauffret, Emmanuelle ;

Pavlyuk, Maria ;

Kraemer, Sandrine ;

Bidard, Francois-Clement ;

Viens, Patrice .

LANCET ONCOLOGY, 2012, 13 (04) :375-384

[9] Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto) [J].

von Minckwitz, G. ;

Loibl, S. ;

Untch, M. ;

Eidtmann, H. ;

Rezai, M. ;

Fasching, P. A. ;

Tesch, H. ;

Eggemann, H. ;

Schrader, I. ;

Kittel, K. ;

Hanusch, C. ;

Huober, J. ;

Solbach, C. ;

Jackisch, C. ;

Kunz, G. ;

Blohmer, J. U. ;

Hauschild, M. ;

Fehm, T. ;

Nekljudova, V. ;

Gerber, B. .

ANNALS OF ONCOLOGY, 2014, 25 (12) :2363-2372

[10] Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis [J].

Wang, Yuting ;

Zhang, Chengpeng ;

Liu, Jianjun ;

Huang, Gang .

BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) :357-369

← 1 →